Overall Technical outlook

Price Summary

On 2025-06-13, NATCO Pharma Limited's stock opened at 896.05, reached a high of 923.8, dropped to a low of 890.75, and closed higher 1.86% at 912.7, with a trading volume of 1294185 shares.
The highest price the stock achieved in the past 52 weeks is 1592.85, while the lowest price it saw is 746.5.
12 analysts estimate that the future price of NATCOPHARM will fall between 710.0 and 1675.0, with an average price expectation of approximately 1099.3334.

Technicals

Support and Resistance: The current price of 912.7 is supported at 902.85, with resistance at 1146.35. This suggests that the price for NATCOPHARM might remain between these levels, where 902.85 acts as a floor and 1146.35 as a ceiling in the market.
NATCOPHARM supportResistance f0e2bf
Support/Resistance for NATCOPHARM


Aroon: The AROON is showing a neutral stance, not indicating a clear upward or downward trend for NATCO Pharma Limited. This suggests a period of market balance, where neither side is showing dominance.
NATCOPHARM aroon f0e2bf
Aroon chart for NATCO Pharma Limited


Bol. Bands: The current state of the BOLL BANDS is neutral, offering no clear signals of movement in either direction. This suggests a potential pause in market activity, with no strong trend emerging at the moment.
NATCOPHARM bbands f0e2bf
Bolinger Bands chart for NATCO Pharma Limited


Parabolic SAR: The PSAR remains bullish, setting a strong support level that could underpin further upward movement. This persistent bullish outlook suggests that the market may continue its positive trajectory, with the established support acting as a safety net.
NATCOPHARM psar f0e2bf
Parabolic Stop and Reverse chart for NATCO Pharma Limited


Stochastic: The STOCHASTIC is currently in a neutral position for NATCO Pharma Limited, offering no clear guidance on whether the market is likely to move up or down. This neutral stance suggests that further observation may be necessary before a trend becomes apparent.
NATCOPHARM stoch f0e2bf
Stochastic chart for NATCO Pharma Limited


Tripple Moving Agerage: The Tripple MOVING AVG is in a neutral stance, not pointing to a clear trend in either direction. This suggests that the market may be lacking strong momentum, making it difficult to predict the next move.
NATCOPHARM trippleSMA f0e2bf
Tripple SMA chart for NATCO Pharma Limited


A thorough analysis of a company involves looking at both its fundamentals and technical data. The fundamentals, including revenue, profitability, and management quality, offer insight into the company's long-term value. Additionally, understanding the broader industry context, such as market competition and regulatory challenges, helps to better interpret the company's stock performance. By combining both fundamental and technical analysis, you can derive more meaningful inferences about the company's future prospects.